Oocyte donation treats infertility in survivors of malignancies: ten-year experience.
Women who are survivors of malignancy may achieve pregnancy through oocyte donation.  The largest obstacle to successful reproduction in cancer patients relates to iatrogenic damage to the primary reproductive organs associated with their primary oncology treatment.  Reactive damage from surgery, radiation, or chemotherapy may render these organs nonfunctional and irreparable.  In cases where the ovary is primarily affected, oocyte donation provides a logical alternative for childbearing.
Kavic
S M
SM
Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Columbia University College of Physicians and Surgeons, Columbia-Presbyterian Medical Center, New York, New York, USA.
Sauer
M V
MV
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004624:Embryo Transfer; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000628:therapy; D018587:Oocyte Donation
D000970:Antineoplastic Agents